Developing magnetic endoscopy devices to treat digestive-tract pouches
Digestive-tract pouches can retain food and cause pain, regurgitation and difficulty eating. These structural problems can arise after gastric bypass or stomach removal, or develop in the esophagus. Correcting them may require another invasive operation and further recovery.
Slow Surg is developing MAGUS, an endoscopically placed magnetic device for digestive-tract pouches. It gradually divides a tissue partition to open the pouch into the digestive passage, aiming to relieve symptoms while avoiding repeat invasive surgery.
What stands out about Slow Surg
In a 2022 pre-spinout series of 14 Candy Cane Syndrome patients, MAGUS improved symptom scores at 3 months.
MAGUS-CCS started at Erasme Hospital in August 2023, with planned enrolment of 51 participants.
Listed by ULB as a 2025 spin-off developing a device for post-bypass complications and digestive-tract deformities.
Co-founder Nicolas Cauche previously founded Brussels Medical Device Center and co-founded endoscopic-device company Endo Tools Therapeutics.
Co-founder Cédric Szpirer founded Delphi Genetics, acquired by Catalent in February 2021 for $50M in equity consideration, subject to adjustments.
Co-founder Jacques Devière is a gastroenterologist at Erasme Hospital and a clinical investigator behind MAGUS development.
The pre-company MAGUS research project received Innoviris Brussels support under grant RBC/2017-SOIB-9.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.